IP Library Granted Patent US 9,095,625
Granted Patent B2
US 9,095,625 · App. 13/826,064 · Granted Aug 4, 2015

Graft-copolymer stabilized metal nanoparticles

Inventor: Alexei A. Bogdanov (Westborough, MA)
Assignee: University of Massachusetts
A61K47/48315A61K47/48884Y10T428/2998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,625
App. No.
13/826,064
Granted
Aug 4, 2015
Kind
B2
Abstract

There is provided a method of preparing nanoparticles and novel nanoparticles. The nanoparticle preparation comprises the generation of a mixture comprising a plurality of metal-containing compounds and a copolymer of a polyethylene glycol and an amine-containing polyamino acid such as polylysine where a metal core and polymer shell nanoparticle is formed. The novel nanoparticles have a metallic core and a graft copolymer shell of polyethylene glycol and an amine-containing polyamino acid where the shell least partially surrounds the metallic core and is non-ionically bound to the metallic core via metal-amine bonds.

Claims (25)

1. A nanoparticle comprising:

a metallic core, and

a copolymer shell of a polyethylene glycol and an amine-containing polyamino acid that at least partially surrounds the metallic core,

wherein said copolymer shell is non-ionically bound to said metallic core via metal-amine bonds, and

wherein said nanoparticle is a non-aggregating nanoparticle, and

wherein said amine-containing polyamino acid is any of poly-L-lysine and poly-D-lysine.

2. The nanoparticle of claim 1 , wherein said nanoparticle has a Zeta potential in the range of about −14 to about +10 mV.

3. The nanoparticle of claim 1 , wherein said metallic core is about 5-25 nm in diameter and the nanoparticle has a hydrodynamic diameter in the range of about 10-100 nm.

4. The nanoparticle of claim 1 , wherein said polyethylene glycol comprises about 90-95% and said amine-containing polyamino acid comprises about 5-10% of said copolymer.

5. The nanoparticle of claim 1 , wherein said metallic core comprises gold.

6. The nanoparticle of claim 1 , wherein said metallic core comprises gold and one or more of platinum (II) and silver.

7. The nanoparticle of claim 1 , wherein said copolymer is acylated at the N-ε-amino.

8. The nanoparticle of claim 7 , wherein approximately 10-20% of the copolymer N-ε-amino groups are acylated.

9. The nanoparticle of claim 1 , wherein said polyethylene glycol is a methoxy polyethylene glycol (MPEG) or derivative thereof.

10. The nanoparticle of claim 9 , wherein said derivative of MPEG is an N-hydroxysuccinimide ester, imidazolide, a pentafluorophenyl ester, or an ethylthioacetate of MPEG or said derivative is O-Methyl(PEG))-O′-succinate.

11. The nanoparticle of claim 1 , wherein said copolymer has the structure:

wherein R 1 is hydrogen, a lower alkyl, or a protecting group and n is 20-220.

12. The nanoparticle of claim 1 , wherein at least about 50% of the copolymers in said shell are non-ionically bound to said metallic core via metal-amine bond.

13. The nanoparticle of claim 1 , wherein said copolymer shell covers at least about 50 percent of said metallic core.

14. The nanoparticle of claim 1 , wherein said copolymer shell covers at least about 75 percent of said metallic core.

15. The nanoparticle of claim 1 , wherein said copolymer shell covers at least about 80 percent of said metallic core.

16. The nanoparticle of claim 1 , wherein said copolymer shell covers at least about 90 percent of said metallic core.

17. The nanoparticle of claim 1 , further comprising an imaging or therapeutic moiety attached to said copolymer shell.

18. The nanoparticle of claim 1 , further comprising an imaging or therapeutic moiety that forms an ionic complex with said nanoparticle.

19. The nanoparticle of claim 18 , wherein said therapeutic moiety is a short negatively charged oligonucleotide or oligonucleotide duplex.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 20, 2017
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042285/0998 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2015
From: BOGDANOV, ALEXEI A
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 035028/0991 →
Continuity (2)
Provisional Application 61695576 · Aug 31, 2012
Related Publication 20140065425A1 · Mar 6, 2014